Solarea Bio
PrivateLast Round
Grant
Aug 23, 2023
Total Funding Raised
$14.4M
Company Overview
Solarea Bio is a biotechnology company that develops microbiome-based medical foods and therapeutics designed to address age-related inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, D2C Brands, Drug Discovery
Business Model
B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solarea Bio Comparables
Compare Solarea Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pendulum Therapeutics | 65% | |
| Symrise AG | 64% | |
| BioGaia AB (publ) | 62% | |
Solarea Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 23, 2023 | ||||
| Series B | May 8, 2023 | ||||
| Series A | Oct 19, 2020 | ||||
| Accelerator | Jul 26, 2017 |
Solarea Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viking Global Investors | Series A, Series B |
| National Institute on Aging | Grant |
| BOLD Capital Partners | Series B, Series A |
| S2G Investments | Series A, Series B |
| Illumina Accelerator | Accelerator |
Solarea Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Solarea Bio's valuation, stock price, and market status.